http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2702611-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be6acd695bf2733a1bdd0406e188c0b3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 |
| filingDate | 2018-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa3d89ab9c2ae5805e63d369c80f92d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac7ed762b5cf4a692029866d7c75ed5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f6d19d915f4d66d28dff10e563aabcb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_617df48c30d2b8dd2b2e55bdf7f6435f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5f82f3b9eccac35dc42108f92bb2096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66531deea1343b544a73a0d9fe68c3ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c2296567a21ebe65e5f3fcadefe44f9 |
| publicationDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2702611-C1 |
| titleOfInvention | Method for prediction of low-energy bone fractures in patients with rheumatoid arthritis |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to rheumatology, therapy, clinical-laboratory diagnostics, and can be used in predicting the probability of developing low-energy bone fractures in patients with rheumatoid arthritis (RA). That is ensured by determining blood serum of the iris protein in the patient's blood serum. If the blood poisonin concentration is 10.85 mcg/ml and lower, a high risk of developing bone fractures is diagnosed. If blood serum concentration exceeds 10.85 mcg/ml, a low risk of fractures is diagnosed. n EFFECT: method provides accurate prediction of the risk of developing low-energy bone fractures in the RA patients by determining the blood serum protein concentration possessing the mykinin properties, which participates in the pathogenesis of RA. n 1 cl, 3 ex |
| priorityDate | 2018-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.